agilon health, inc.

AGL

US00857U1079

Healthcare Facilities & Services

Real-time Estimate Cboe BZX Other stock markets 19:21:00 15/05/2024 BST			5-day change	1st Jan Change
5.385 ^USD	-2.09%		+3.66%	-57.13%

05-09	Deutsche Bank Adjusts agilon health Price Target to $5 From $8, Maintains Hold Rating	MT
05-07	Transcript : Agilon health, inc., Q1 2024 Earnings Call, May 07, 2024

Agilon health, inc. Provides Earnings Guidance for the Year Ending December 31, 2024

January 05, 2024 at 11:00 am

agilon health, inc. provided earnings guidance for the year ending December 31, 2024. For the year, the company expects total revenue of $6,350 million to $6,420 million.

Latest news about agilon health, inc.

Deutsche Bank Adjusts agilon health Price Target to $5 From $8, Maintains Hold Rating	05-09	MT
Transcript : Agilon health, inc., Q1 2024 Earnings Call, May 07, 2024	05-07
Earnings Flash (AGL) AGILON HEALTH Posts Q1 Revenue $1.60B, vs. Street Est of $1.61B	05-07	MT
Agilon health, inc. Provides Earnings Guidance for the Second Quarter Ending June 30, 2024	05-07	CI
Agilon health, inc. Revises Earnings Guidance for the Year Ending December 31, 2024	05-07	CI
Agilon health, inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-07	CI
Agilon health Announces to Enter State of Illinois for First Time	05-07	CI
Agilon health Announces New Physician Partnerships for 2025	05-07	CI
Citigroup Starts agilon health With Neutral Rating, $6 Price Target	04-22	MT
Barclays Initiates Agilon Health With Underweight Rating, Price Target is $5	03-06	MT
Transcript : Agilon health, inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-05-2024 12:50 PM	03-05
Deutsche Bank Cuts Agilon Health's Price Target to $8 From $10, Maintains Hold Rating	02-29	MT
Truist Securities Cuts Price Target on Agilon Health to $7.50 From $10, Maintains Hold Rating	02-29	MT
RBC Cuts Price Target on Agilon Health to $8 From $11, Says Near Term 'Could Remain Choppy,' Keeps Outperform Rating	02-28	MT
Agilon Health Q4 Loss Widens, Revenue Rises	02-28	MT
Transcript : Agilon health, inc., Q4 2023 Earnings Call, Feb 27, 2024	02-27
Earnings Flash (AGL) AGILON HEALTH Reports Q4 Revenue $1.06B, vs. Street Est of $1.02B	02-27	MT
Agilon health, inc. Provides Revenue Guidance for the First Quarter Ending March 31, 2024	02-27	CI
Agilon health, inc. Revises Revenue Guidance for the Full Year Ending December 31, 2024	02-27	CI
Agilon health, inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-27	CI
Agilon health, inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-27	CI
North American Morning Briefing : Stock Futures -2-	02-27	DJ
TD Cowen Downgrades Agilon Health to Market Perform From Outperform	02-26	MT
Agilon Health Names Karthik Rao Interim Chief Medical Officer	02-09	MT
Agilon health, inc. Announces Executive Changes	02-08	CI

agilon health, inc. is a healthcare company. It enables primary care physicians (PCP) to be the agents for change in the communities they serve. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partnersâ attributed patients (or global capitation arrangements). It focuses on community-based physician groups and is built around three key elements: agilonâs platform, agilonâs long-term physician partnership approach, and agilonâs network. The agilon platform is holistic in supporting the rapid transition to a Total Care Model with technology, people, process and capital.

Sector

Healthcare Facilities & Services

Calendar

29/05/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for agilon health, inc.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

5.5 USD

Average target price

8.053 USD

Spread / Average Target

+46.42%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Doctor's Office

	1st Jan change	Capi.
AGILON HEALTH, INC.	-57.13%	2.26B
HUAXIA EYE HOSPITAL GROUP CO.,LTD.	-21.78%	2.93B
TOPCHOICE MEDICAL CO., INC.	-16.39%	2.92B
EUROEYES INTERNATIONAL EYE CLINIC LIMITED	+5.57%	234M
MEDSCI HEALTHCARE HOLDINGS LIMITED	-41.30%	192M
AESTHETIC CONNECT	-40.78%	108M

Doctor's Office